The Animal Cell Technology Unit, coordinated by Paula Alves, is a top research group that combines the knowledge and competences required to develop biopharmaceuticals and their integrated processing as well as in vitro tools for pre-clinical research.
Our research focuses on four main areas:
- Cell line development
- Recombinant proteins including monoclonal antibodies
- Viral vaccines
- Viral vectors for gene therapy
The unit is involved in several national and international projects under the 6th, 7th and H2020 Framework of European Commission Programs and is a member of CLINIGENE, an international Network of Excellence in Gene and Cell therapy. The group has also research projects with the BioPharma Industry and Biotech SMEs.